HUM HUMANA INC
Hospital & Medical Service Plans · NYSE · SEC CIK 49071 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY22.0%
TTM net income YoY-3.5%
TTM EPS YoY-4.1%
Revenue 3-yr CAGR14.6%
Net income 3-yr CAGR-25.5%
Margins
Gross margin—
Operating margin1.5%
Net margin0.8%
FCF margin2.0%
EBITDA margin2.0%
Returns
ROE6.7%
ROA2.3%
ROIC (approx.)7.0%
Asset turnover2.88x
Leverage & solvency
Liabilities / assets67.0%
Debt / equity0.66x
Current ratio1.65x
Interest coverage3.16x
Cash quality & payout
Operating cash flow / net income2.99x
Accruals ratio-4.6%
Payout ratio34.4%
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| SG&A expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B |
| Operating income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B |
| Interest expense | $631.00M | $660.00M | $493.00M | $401.00M | $326.00M |
| Pretax income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B |
| Income tax | $250.00M | $413.00M | $836.00M | $762.00M | $485.00M |
| Net income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| EBITDA | $3.40B | $3.40B | $4.79B | $4.51B | $3.74B |
| EPS (basic) | 9.87 | 10.01 | 20.09 | 22.20 | 22.79 |
| EPS (diluted) | 9.84 | 9.98 | 20.00 | 22.08 | 22.67 |
| Dividends declared per share | 3.54 | 3.54 | 3.44 | 3.06 | 2.73 |
| Weighted avg. shares (diluted) | 120.83M | 120.87M | 124.44M | 127.09M | 129.40M |
| Balance sheet | |||||
| Cash & equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B |
| Short-term investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B |
| Current assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B |
| PP&E, net | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B |
| Total assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B |
| Current liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B |
| Short-term debt | $0 | $577.00M | $1.44B | $2.09B | $1.95B |
| Long-term debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B |
| Total debt | $12.37B | $11.72B | $11.66B | $11.13B | $12.49B |
| Total liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B |
| Shareholders' equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B |
| Net debt | $8.17B | $9.50B | $6.96B | $6.07B | $9.10B |
| Cash flow statement | |||||
| Operating cash flow | $921.00M | $2.97B | $3.98B | $4.59B | $2.26B |
| Capital expenditure | $546.00M | $575.00M | $1.00B | $1.14B | $1.34B |
| Free cash flow | $375.00M | $2.39B | $2.98B | $3.45B | $920.00M |
| Investing cash flow | $2.27B | -$2.95B | -$3.49B | -$1.01B | -$6.56B |
| Financing cash flow | -$1.22B | -$2.49B | -$856.00M | -$1.91B | $3.02B |
| Depreciation & amortization | $698.00M | $839.00M | $779.00M | $709.00M | $596.00M |
| Stock-based compensation | $241.00M | $207.00M | $175.00M | $216.00M | $180.00M |
| Dividends paid | $430.00M | $431.00M | $431.00M | $392.00M | $354.00M |
| Share buybacks | $151.00M | $817.00M | $1.57B | $2.10B | $79.00M |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.